Business Description
Navamedic ASA
SIC : 2834
ISIN : NO0010205966
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.63 | |||||
Debt-to-EBITDA | 2.98 | |||||
Interest Coverage | 7.95 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.82 | |||||
Beneish M-Score | -2.18 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.1 | |||||
3-Year FCF Growth Rate | -3 | |||||
3-Year Book Growth Rate | 22.2 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.35 | |||||
9-Day RSI | 43.04 | |||||
14-Day RSI | 42.79 | |||||
6-1 Month Momentum % | -0.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.67 | |||||
Quick Ratio | 1.16 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 99.99 | |||||
Days Sales Outstanding | 48.16 | |||||
Days Payable | 94.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.2 | |||||
Shareholder Yield % | -4.96 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 41.72 | |||||
Operating Margin % | 7.64 | |||||
Net Margin % | 4.46 | |||||
FCF Margin % | 6.79 | |||||
ROE % | 10.01 | |||||
ROA % | 4.81 | |||||
ROIC % | 7.34 | |||||
ROC (Joel Greenblatt) % | 111.99 | |||||
ROCE % | 13.47 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 28.82 | |||||
PE Ratio without NRI | 20.57 | |||||
Price-to-Owner-Earnings | 37.47 | |||||
PS Ratio | 1.3 | |||||
PB Ratio | 2.79 | |||||
Price-to-Free-Cash-Flow | 18.57 | |||||
Price-to-Operating-Cash-Flow | 17.28 | |||||
EV-to-EBIT | 18.49 | |||||
EV-to-EBITDA | 15.35 | |||||
EV-to-Revenue | 1.52 | |||||
EV-to-FCF | 22.32 | |||||
Price-to-Projected-FCF | 3.04 | |||||
Price-to-Median-PS-Value | 2.45 | |||||
Earnings Yield (Greenblatt) % | 5.41 | |||||
FCF Yield % | 5.19 | |||||
Forward Rate of Return (Yacktman) % | -9.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Navamedic ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 454.464 | ||
EPS (TTM) (kr) | 1.18 | ||
Beta | -0.9 | ||
Volatility % | 29.44 | ||
14-Day RSI | 42.79 | ||
14-Day ATR (kr) | 0.934511 | ||
20-Day SMA (kr) | 34.655 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (kr) | 31 - 43.9 | ||
Shares Outstanding (Mil) | 17.43 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Navamedic ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Navamedic ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Navamedic ASA Frequently Asked Questions
What is Navamedic ASA(OSL:NAVA)'s stock price today?
When is next earnings date of Navamedic ASA(OSL:NAVA)?
Does Navamedic ASA(OSL:NAVA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |